SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 26, 2004
VAXGEN, INC.
(Exact name of Registrant as Specified in its Charter)
DELAWARE 0-26483 94-3236309
(State or other jurisdiction of (Commission (I.R.S. Employer
incorporation or organization) File Number) Identification Number)
1000 MARINA BLVD., SUITE 200 BRISBANE, CALIFORNIA 94005
(Address of Principal Administrative Offices)
Registrants Telephone Number, Including Area Code: (650) 624-1000
Item 5. Other Events.
On July 26, 2004, VaxGen, Inc. (the "Company") was notified by William
Young that he was resigning from the Company's Board of Directors, effective
immediately. On July 30, 2004, the Company issued a press release entitled,
"VaxGen Announces Appointment of Randall Caudill as Board Chairman and
Resignation of William Young; CEO Lance Gordon Named to Additional Post of
President".
This press release is attached as Exhibit 99.1 to this report and is
incorporated herein by reference.
Item 7. Financial Statements and Exhibits.
(a) Financial statements of business acquired. Not applicable.
(b) Pro forma financial information. Not applicable.
(c) Exhibits.
Exhibit No. Description
- ----------- -----------
99.1 Press release issued by VaxGen, Inc., on July 30, 2004
entitled, "VaxGen Announces Appointment of Randall Caudill as
Board Chairman and Resignation of William Young; CEO Lance
Gordon Named to Additional Post of President".
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
VaxGen, Inc.
(Registrant)
Dated: July 30, 2004
By: /s/ James M. Cunha
-----------------------------
James M. Cunha
Chief Financial Officer